Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy and prevention of hyperthyroidism].

U Woenckhaus1, C Girlich

  • 1Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität, 93042 Regensburg. ulrike.woenckhaus@klinik.uni-regensburg.de

Der Internist
|October 19, 2005
PubMed
Summary

A decreased serum TSH level affects over 10% of the German population. Unrecognized autonomous thyroid dysfunction poses a risk for developing thyrotoxicosis, especially with iodine exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Confusion, tachypnea, and tachycardia in a 71-year-old man with type 2 diabetes mellitus].

Der Internist·2021
Same author

[Thyroid dysfunction in elderly patients].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Treatment of type 2 diabetes in elderly patients].

Der Internist·2014
Same author

[A 43-year-old patient with character changes, recurrent impaired consciousness and retrograde amnesia].

Der Internist·2014
Same author

Topical delivery of steroids in inflammatory bowel disease.

Current drug delivery·2012
Same author

[Contrast-enhanced sonographic drainage control: a feasibility study].

Zeitschrift fur Gastroenterologie·2011

Area of Science:

  • Endocrinology
  • Internal Medicine

Context:

  • Decreased serum TSH levels are prevalent in over 10% of the German population.
  • Autonomous thyroid dysfunction carries a risk of developing thyrotoxicosis upon iodine exposure.
  • Graves' disease is a primary cause of hyperthyroidism in younger individuals.

Purpose:

  • To outline the risks associated with unrecognized autonomous thyroid dysfunction.
  • To discuss current preventive and therapeutic strategies for hyperthyroidism, including antithyroid drugs and definitive treatments.
  • To highlight ongoing research into predictors of relapse and novel therapeutic approaches like selenium supplementation for autoimmune thyroid disease.

Summary:

  • Management of decreased serum TSH levels involves preventive and therapeutic measures, particularly for patients with unrecognized autonomous thyroid dysfunction.
  • Antithyroid drugs are a primary medical treatment for Graves' disease, aiming for remission after 12-18 months.
  • Research is exploring predictors for relapse and the potential of selenium supplementation in autoimmune thyroid disease, though robust clinical trial data is pending.

Impact:

  • Informs clinical practice regarding the management of subclinical hypothyroidism and autonomous thyroid dysfunction.
  • Guides treatment decisions for hyperthyroidism, balancing medical therapy with definitive interventions.
  • Identifies areas for future research in predicting relapse and evaluating new treatments for thyroid disorders.

Related Experiment Videos